The Cancer Letter

Inside information on cancer research and drug development

Vol.
25
No.
24
June 16, 1999Jun 16, 1999
Free
DOWNLOAD THE PDF

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

FDA Official Outlines agency’s Views On Efficacy Requirement

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account